Jammu, India

Rajinder Singh

This inventor holds 2 USPTO granted patents. Top assignee: Council of Scientific and Industrial Research. Active years: 2003-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rajinder Singh. Retrieved from https://idiyas.com/inventor/rajinder-singh-8v6efmbx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 2003-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rajinder Singh: Innovator in Pharmaceutical Research

Introduction

Rajinder Singh is a notable inventor based in Jammu, India. He has made significant contributions to the field of pharmaceutical research, particularly in the treatment of diabetes. With a total of 2 patents to his name, Singh's work is recognized for its innovative approach to health solutions.

Latest Patents

Singh's latest patents include the compound 8-(C-β-D-glucopyranosyl)-7,3',4'-trihydroxyflavone, which is isolated for its potential use in diabetes treatment. This invention not only introduces a novel compound but also outlines a method for its preparation and various applications. Another significant patent involves glucopyranoside and its isolation process from Pterocarpus marsupium, along with a pharmaceutical composition containing the same and its uses.

Career Highlights

Rajinder Singh is affiliated with the Council of Scientific and Industrial Research, where he has been instrumental in advancing research in pharmaceuticals. His dedication to innovation has led to breakthroughs that could improve the quality of life for many individuals suffering from diabetes.

Collaborations

Singh has worked alongside esteemed colleagues such as Sukhdev Swami Handa and Rakesh Maurya, contributing to a collaborative environment that fosters innovation and research excellence.

Conclusion

Rajinder Singh's contributions to pharmaceutical research highlight his commitment to developing effective treatments for diabetes. His innovative patents and collaborative efforts underscore the importance of research in improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…